PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin
Clinical trial NCT02206100 · COMPLETED
Trial details
- NCT number
- NCT02206100
- Sponsor
- Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2014-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.